11/29/2023  4:27:00 PM Chg. +0.250 Volume Bid4:31:41 PM Ask4:31:46 PM Market Capitalization Dividend Y. P/E Ratio
17.550EUR +1.45% 19,478
Turnover: 339,241.600
17.530Bid Size: 135 17.570Ask Size: 125 1.28 bill.EUR 1.42% 18.28

Business description

Fagron N.V. specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The group ensures the sale of pharmaceutical formulas and raw materials, provides third-party pharmaceutical compounding services to pharmacists and hospitals, etc.
 

Management board & Supervisory board

CEO
Rafael Padilla
Management board
Karin de Jong, Vera Bakker, Maarten Pouw, Andrew Pulido, Geraldino Neder, Johan Verlinden
Supervisory board
Koen Hoffman, Karin de Jong, Neeraj Sharma, Klaus Röhrig, Els Vandecandelaere, Rob ten Hoedt, Ann Desender
 

Company data

Name: Fagron NV
Address: Venecoweg 20A,BE-9810 Nazareth, Oost-Vlaanderen
Phone: +32 88 33 11 288
Fax: -
E-mail: -
Internet: https://investors.fagron.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: -
IPO date: 10/5/2007

Investor relations

Name: -
IR phone: +31 88 33 11 200
IR Fax: -
IR e-mail: investors@fagron.com

Main Shareholders

Others
 
44.27%
The Goldman Sachs Group, Inc.
 
18.09%
NN Group N.V.
 
15.90%
AOC Pharma S.à.r.l.
 
8.74%
FMR LLC
 
4.99%
Alychlo NV
 
4.99%
Mawer Investment Management Ltd.
 
3.02%